-+ 0.00%
-+ 0.00%
-+ 0.00%

Contineum Therapeutics grants 102,000 inducement stock options to new hires

PUBT·05/01/2026 20:05:17
Listen to the news
Contineum Therapeutics grants 102,000 inducement stock options to new hires
  • Contineum Therapeutics granted inducement equity awards to two new non-executive employees under its 2026 Employment Inducement Equity Incentive Plan.
  • Each hire received a non-qualified stock option covering 51,000 shares of Class A common stock.
  • Grants were dated April 28, 2026, and April 30, 2026.
  • Options carry an exercise price equal to closing share price on each grant date.
  • Vesting runs over four years, starting with 25% after one year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260501358168) on May 01, 2026, and is solely responsible for the information contained therein.